InvestorsHub Logo
Followers 3
Posts 52
Boards Moderated 0
Alias Born 05/05/2022

Re: None

Thursday, 05/12/2022 2:37:37 PM

Thursday, May 12, 2022 2:37:37 PM

Post# of 567
New compound, new force foe a gain, hang in there, this will pop sooner than we think.
HM43239 Myeloid Kinome Aptose WW
AMLPreclinical Phase complete
Clinical Proof-of-Concept Phase in progress
Pivotal Phase not started
Luxeptinib Lymphoid Kinome Aptose: WW
Crystal Genomics: Korea
CLL & NHLPreclinical Phase complete
Clinical Proof-of-Concept Phase in progress
Pivotal Phase not started
Luxeptinib Myeloid Kinome Aptose: WW
Crystal Genomics: Korea
AML & MDSPreclinical Phase complete
Clinical Proof-of-Concept Phase in progress
Pivotal Phase not started
APTO-253 MYC Aptose: WW
AML & MDSPreclinical Phase complete
Clinical Proof-of-Concept Phase in progress
Pivotal Phase not started
APL-581 BRD4/JAK Aptose and Ohm
Hematologic CancersPreclinical Phase in progress
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News